Results 221 to 230 of about 378,823 (394)

Burden of allergic rhinitis in the United Kingdom. [PDF]

open access: yesFront Allergy
Jones M   +7 more
europepmc   +1 more source

The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE‐D Study

open access: yesAllergy, EarlyView.
An online expert‐designed questionnaire estimated the international prevalence of dermographism. Symptomatic dermographism, physiological red dermographism, and simple urticarial dermographism exhibit distinct prevalence patterns across age groups, sex, and geographic regions. Symptomatic dermographism has an international point prevalence of 3.20% (95%
Kanokvalai Kulthanan   +55 more
wiley   +1 more source

Nasal airway resistance in moderately severe allergic rhinitis and impact of Vitamin D deficiency

open access: diamond
Diwash Sunar   +6 more
openalex   +1 more source

International Evidence‐Based Guidelines for Traditional Chinese Medicine Management of Allergic Rhinitis

open access: yesAllergy, EarlyView.
ABSTRACT Allergic rhinitis (AR) is a prevalent chronic condition that significantly impacts patients' quality of life and poses challenges to effective management. Traditional Chinese medicine (TCM) offers a holistic approach, emphasizing syndrome differentiation, individualized care, and natural treatment strategies.
Qin‐Wei Fu   +74 more
wiley   +1 more source

Chinese expert consensus on intranasal anticholinergics for allergic rhinitis. [PDF]

open access: yesAsia Pac Allergy
Li X   +26 more
europepmc   +1 more source

Deficiency of Vitamin D in Allergic Rhinitis: A Possible Factor in Multifactorial Disease

open access: bronze, 2014
Anil Jain   +5 more
openalex   +1 more source

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions

open access: yesAllergy, EarlyView.
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy